Vision Care - Medical Devices Pipeline Assessment, 2016

  • ID: 3980955
  • Report
  • 298 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Abbott Medical Optics Inc
  • Adoptics AG
  • AkkoLens International BV
  • Alcon, Inc.
  • Anew Optics, Inc.
  • Bausch & Lomb Inc
  • MORE
Vision Care - Medical Devices Pipeline Assessment, 2016

Summary

“Vision Care - Medical Devices Pipeline Assessment, 2016 provides an overview of Vision Care currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vision Care under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vision Care and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vision Care under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Medical Optics Inc
  • Adoptics AG
  • AkkoLens International BV
  • Alcon, Inc.
  • Anew Optics, Inc.
  • Bausch & Lomb Inc
  • MORE
2 Introduction

2.1 Vision Care Overview

3 Products under Development

3.1 Vision Care - Pipeline Products by Stage of Development

3.2 Vision Care - Pipeline Products by Segment

3.3 Vision Care - Pipeline Products by Territory

3.4 Vision Care - Pipeline Products by Regulatory Path

3.5 Vision Care - Pipeline Products by Estimated Approval Date

3.6 Vision Care - Ongoing Clinical Trials

4 Vision Care - Pipeline Products under Development by Companies

4.1 Vision Care Companies - Pipeline Products by Stage of Development

4.2 Vision Care - Pipeline Products by Stage of Development

5 Vision Care Companies and Product Overview

5.1 Adventus Technology Inc Company Overview

5.1.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aeon Astron Corporation Company Overview

5.2.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.3 Alcon, Inc. Company Overview

5.3.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.4 Apeliotus Ophthalmics Company Overview

5.4.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview

5.5 Auburn University Company Overview

5.5.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview

5.6 Axcelon Biopolymers Corp. Company Overview

5.6.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview

5.7 Bar-Ilan University Company Overview

5.7.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview

5.8 Bausch & Lomb Inc Company Overview

5.8.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 Bionic Eye Technologies, Inc. Company Overview

5.9.1 Bionic Eye Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.10 Bionic Vision Australia Company Overview

5.10.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview

5.11 Children's Hospital Boston Company Overview

5.11.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview

5.12 Consejo Superior de Investigaciones Cientificas Company Overview

5.12.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview

5.13 CooperVision Inc Company Overview

5.13.1 CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Cornea Biosciences Company Overview

5.14.1 Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview

5.15 Cornell University Company Overview

5.15.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview

5.16 EP Global Communications, Inc. Company Overview

5.16.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.17 eSight Corporation Company Overview

5.17.1 eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.18 Euclid Systems Corporation Company Overview

5.18.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.19 Eyenovations Company Overview

5.19.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview

5.20 EyeYon Medical Company Overview

5.20.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview

5.21 iBionics Inc Company Overview

5.21.1 iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Imperial College London Company Overview

5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

5.23 iSTAR Medical SA Company Overview

5.23.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview

5.24 John Hopkins University Company Overview

5.24.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.25 Johnson & Johnson Vision Care Inc Company Overview

5.25.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview

5.26 Massachusetts Eye and Ear Infirmary Company Overview

5.26.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

5.27 McGill University Company Overview

5.27.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview

5.28 Mercy Research and Development Company Overview

5.28.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview

5.29 Meta Biomed Co Ltd Company Overview

5.29.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.30 Microbiosensor Ltd Company Overview

5.30.1 Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.31 Monash University Company Overview

5.31.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview

5.32 Nano Retina, Inc. Company Overview

5.32.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.33 Novartis AG Company Overview

5.33.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview

5.34 Ocular Dynamics, LLC Company Overview

5.34.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.35 Ocutec Ltd Company Overview

5.35.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.36 PixelOptics Inc Company Overview

5.36.1 PixelOptics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.37 Pixium Vision Company Overview

5.37.1 Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview

5.38 Presbia Plc Company Overview

5.38.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview

5.39 Queensland University of Technology Company Overview

5.39.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.40 Refocus Group Inc Company Overview

5.40.1 Refocus Group Inc Pipeline Products & Ongoing Clinical Trials Overview

5.41 RetMap Inc Company Overview

5.41.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview

5.42 ReVision Optics Inc Company Overview

5.42.1 ReVision Optics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.43 Royal College of Surgeons in Ireland Company Overview

5.43.1 Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview

5.44 Stanford University Company Overview

5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.45 Studio Oculistico Gualdi Company Overview

5.45.1 Studio Oculistico Gualdi Pipeline Products & Ongoing Clinical Trials Overview

5.46 Tel Aviv University Company Overview

5.46.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

5.47 The Hong Kong University of Science and Technology Company Overview

5.47.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview

5.48 The University of New South Wales Company Overview

5.48.1 The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview

5.49 UltraVision CLPL Company Overview

5.49.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview

5.50 University of Auckland Company Overview

5.50.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of California San Diego Company Overview

5.51.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

5.52 University of Florida Company Overview

5.52.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

5.53 University of Illinois at Chicago Company Overview

5.53.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.54 University of Oxford Company Overview

5.54.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview

5.55 University of South Florida Company Overview

5.55.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

5.56 University of Tennessee Company Overview

5.56.1 University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview

5.57 University of Valencia Company Overview

5.57.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview

5.58 University of Washington Company Overview

5.58.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.59 Valeant Pharmaceuticals International Inc Company Overview

5.59.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 Va-st Ltd Company Overview

5.60.1 Va-st Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.61 Visioneering Technologies, Inc. Company Overview

5.61.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.62 VISTAKON Pharmaceuticals LLC Company Overview

5.62.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

5.63 Visus Technology, Inc. Company Overview

5.63.1 Visus Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.64 Weill Cornell Medical College Company Overview

5.64.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

5.65 Western University Company Overview

5.65.1 Western University Pipeline Products & Ongoing Clinical Trials Overview

5.66 Yolia Health Company Overview

5.66.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview

5.67 ZircLight Inc. Company Overview

5.67.1 ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Vision Care- Recent Developments

6.1 Nov 16, 2016: New Head of the ZEISS Semiconductor Manufacturing Technology Business Group

6.2 Nov 10, 2016: Alcon introduces new AIR OPTIX plus HydraGlyde monthly replacement contact lenses at the American Academy of Optometry annual meeting

6.3 Nov 10, 2016: ReVision Optics Raises USD32 Million in Venture Financing

6.4 Nov 10, 2016: NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results

6.5 Nov 09, 2016: University of Melbourne and National Vision Research Institute of Australia win $1 M grant to develop diamond bionic eye prototype

6.6 Nov 09, 2016: New Study Shows Groundbreaking Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59% Over Two Years

6.7 Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear

6.8 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results

6.9 Nov 07, 2016: Pixium Vision announces the first successful implantation and activation of IRIS II, 150 electrode bionic vision system, in the UK

6.10 Nov 07, 2016: TearLab Reports Third Quarter and September Year-To-Date 2016 Financial Results

6.11 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results

6.12 Oct 28, 2016: Hoya Reports Second Quarter Results

6.13 Oct 27, 2016: VTI Introduces the NaturalVue Multifocal QuickStart Calculator

6.14 Oct 26, 2016: ZEISS Invests Further 60 Million Euros in the Expansion of the Semiconductor Manufacturing Technology Factory

6.15 Oct 26, 2016: Edmund Optics and Varioptic Announce the Availability of the Variable Focus Arctic Liquid Lens in the EO Catalog

6.16 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters

6.17 Oct 21, 2016: Essilor: Nine-Month Consolidated Revenue up 7.8% at Constant Exchange Rates

6.18 Oct 20, 2016: CollPlant Files Registration Statement to Raise up to USD25 Million in IPO

6.19 Oct 18, 2016: LumiThera to Raise USD5 Million in Venture Financing

6.20 Oct 17, 2016: Wearable Artificial Vision Device Shows Promise in Helping People Who Are Legally Blind Read

6.21 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer

6.22 Oct 12, 2016: Hoya to Acquire Performance Optics for up to USD476 Million

6.23 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer

6.24 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy

6.25 Sep 16, 2016: Johnson & Johnson to Acquire Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion

6.26 Sep 15, 2016: PFO Global Raises USD0.4 Million in Private Placement of Debenture

6.27 Sep 13, 2016: Novartis Raises USD561.78 Million in Public Offering of International Bonds Due 2028

6.28 Sep 13, 2016: Novartis Raises USD1.40 Billion in Public Offering of International Bonds Due 2023

6.29 Sep 12, 2016: Pixium Vision receives clinical trial approval from Spanish Ministry of Health for 150 electrode IRIS II bionic vision system

6.30 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus

6.31 Sep 01, 2016: The Cooper Companies CFO Gregory W. Matz to Retire; Albert G. White Named Successor in Planned Transition

6.32 Sep 01, 2016: The Cooper Companies Announces Third Quarter 2016 Results

6.33 Aug 31, 2016: ReVision Optics Announces First U.S. Commercial Cases of Raindrop Near Vision Inlay

6.34 Aug 30, 2016: FDA-Approved Raindrop Near Vision Inlay Corrects Blurry Reading Vision -- Now Available in Utah for the First Time

6.35 Aug 29, 2016: Drug-dispensing contact lens effectively lowers eye pressure in pre-clinical glaucoma model

6.36 Aug 29, 2016: Drug Dispensing Contact lens Effectively Lowers Eye Pressure in Pre clinical Glaucoma Model

6.37 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer

6.38 Aug 18, 2016: ReVision Optics Secures USD10 Million from Square 1 Bank

6.39 Aug 18, 2016: Luiz de Freitas Joins VISION EASE as Commercial Director for Mexico

6.40 Aug 15, 2016: CooperVision Unveils Avaira Vitality Sphere and Toric Two-Week Contact Lenses

6.41 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery

6.42 Aug 11, 2016: Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent Results

6.43 Aug 11, 2016: NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results

6.44 Aug 10, 2016: ReVision Optics Names Dr. Nick J. Manesis Vice President of R&D

6.45 Aug 10, 2016: Acufocus Raises USD2 Million in Venture Financing

6.46 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation

6.47 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results

6.48 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team

6.49 Aug 03, 2016: STAAR Surgical Reports Second Quarter 2016 Results

6.50 Aug 03, 2016: TearLab Reports Second Quarter and June Year-To-Date 2016 Financial Results

6.51 Aug 01, 2016: Study Shows Corneal Structural Changes Induced by ReVision Optics’ Raindrop Near Vision Inlay Significantly Improve Near and Intermediate Vision in Subjects with Presbyopia

6.52 Aug 01, 2016: NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units

6.53 Aug 01, 2016: Essilor International: Improving Lives by Improving Sight

6.54 Jul 29, 2016: Essilor - First-Half 2016 Results: Revenue Up 8.1% Excluding the Currency Effect

6.55 Jul 29, 2016: Hoya Reports First Quarter Financial Results

6.56 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors

6.57 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization

6.58 Jul 25, 2016: Pixium Vision Announces CE Mark Approval of IRIS II, Its First Bionic Vision System

6.59 Jul 25, 2016: ReVision Optics Appoints Frank Shields Vice President of Sales Worldwide

6.60 Jul 20, 2016: Pixium Vision First Half 2016 Financial Results and Business Update

6.61 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board

6.62 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects

6.63 Jul 18, 2016: Combined Cataract and Presbia Microlens Surgeries Demonstrate Excellent Results and Patient Satisfaction in Near-Vision Improvement

6.64 Jul 14, 2016: Alcon launches Dailies Total1 Multifocal contact lenses, the first and only water gradient lenses designed for people with presbyopia

6.65 Jul 14, 2016: China Grand Pharma Raises USD22 Million in Private Placement of Shares

6.66 Jul 11, 2016: Presbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20th Annual Conference

6.67 Jul 07, 2016: Allergan Demonstrates a Strong Commitment to America's First Responders Donating Over $1 Million Worth of REFRESH Eye Drops

6.68 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS' petition and institutes IPR against NPE patent holder AMI

6.69 Jul 06, 2016: Rayner Continues Growth in Europe with Direct Presence in Italy

7 Appendix

7.1 Methodology

7.2 About Us

7.3 Contact Us

7.4 Disclaimer

List of Tables

Table 1: Vision Care - Pipeline Products by Stage of Development

Table 2: Vision Care - Pipeline Products by Segment

Table 3: Vision Care - Pipeline Products by Territory

Table 4: Vision Care - Pipeline Products by Regulatory Path

Table 5: Vision Care - Pipeline Products by Estimated Approval Date

Table 6: Vision Care - Ongoing Clinical Trials

Table 7: Vision Care Companies - Pipeline Products by Stage of Development

Table 8: Vision Care - Pipeline Products by Stage of Development

Table 9: Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 10: Corneal Onlay - Product Status

Table 11: Corneal Onlay - Product Description

Table 12: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

Table 13: Biolens - Product Status

Table 14: Biolens - Product Description

Table 15: Body Organ Contact Lens - Product Status

Table 16: Body Organ Contact Lens - Product Description

Table 17: Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 18: AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Status

Table 19: AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Description

Table 20: AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Product Status

Table 21: AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Product Description

Table 22: AIR OPTIX Plus HydraGlyde Monthly Replacement Multifocal Lens - Product Status

Table 23: AIR OPTIX Plus HydraGlyde Monthly Replacement Multifocal Lens - Product Description

Table 24: AIR OPTIX Plus HydraGlyde Monthly Replacement Toric Lens - Product Status

Table 25: AIR OPTIX Plus HydraGlyde Monthly Replacement Toric Lens - Product Description

Table 26: Dailies Total 1 Colors SiHy Lens - Product Status

Table 27: Dailies Total 1 Colors SiHy Lens - Product Description

Table 28: Dailies Total 1 Toric SiHy Lens - Product Status

Table 29: Dailies Total 1 Toric SiHy Lens - Product Description

Table 30: Smart Lens - Diabetes - Product Status

Table 31: Smart Lens - Diabetes - Product Description

Table 32: Weekly WG SiHy Lens - Product Status

Table 33: Weekly WG SiHy Lens - Product Description

Table 34: Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview

Table 35: Comfort Lens - Product Status

Table 36: Comfort Lens - Product Description

Table 37: Contact Lens - Glaucoma - Product Status

Table 38: Contact Lens - Glaucoma - Product Description

Table 39: Auburn University Pipeline Products & Ongoing Clinical Trials Overview

Table 40: Smart Contact Lenses - Product Status

Table 41: Smart Contact Lenses - Product Description

Table 42: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview

Table 43: MC - PHEMA Based Contact Lens - Product Status

Table 44: MC - PHEMA Based Contact Lens - Product Description

Table 45: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview

Table 46: Bionic Contact Lens - Product Status

Table 47: Bionic Contact Lens - Product Description

Table 48: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 49: Ultra Plus Powers Lens - Product Status

Table 50: Ultra Plus Powers Lens - Product Description

Table 51: Ultra Toric Lens - Product Status

Table 52: Ultra Toric Lens - Product Description

Table 53: Bionic Eye Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 54: Retinal Prosthesis System - Product Status

Table 55: Retinal Prosthesis System - Product Description

Table 56: Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview

Table 57: High-Acuity Device With 1024 Electrodes - Product Status

Table 58: High-Acuity Device With 1024 Electrodes - Product Description

Table 59: Wide-View Device With 24-channel - Product Status

Table 60: Wide-View Device With 24-channel - Product Description

Table 61: Wide-View Device With 44-channel - Product Status

Table 62: Wide-View Device With 44-channel - Product Description

Table 63: Wide-View Device With 98 Electrodes - Product Status

Table 64: Wide-View Device With 98 Electrodes - Product Description

Table 65: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview

Table 66: Contact Lens Drug Delivery Device - Product Status

Table 67: Contact Lens Drug Delivery Device - Product Description

Table 68: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview

Table 69: Reduced Optical Instrument - Product Status

Table 70: Reduced Optical Instrument - Product Description

Table 71: CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 72: Biofinity Energys - Product Status

Table 73: Biofinity Energys - Product Description

Table 74: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status

Table 75: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description

Table 76: SiH Multifocal - Product Status

Table 77: SiH Multifocal - Product Description

Table 78: CooperVision Inc - Ongoing Clinical Trials Overview

Table 79: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses

Table 80: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial

Table 81: Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview

Table 82: Bioengineered Cornea - Product Status

Table 83: Bioengineered Cornea - Product Description

Table 84: Cornell University Pipeline Products & Ongoing Clinical Trials Overview

Table 85: Prosthetic Retinal Device - Product Status

Table 86: Prosthetic Retinal Device - Product Description

Table 87: EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 88: EP Global Contact Lens - Product Status

Table 89: EP Global Contact Lens - Product Description

Table 90: eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview

Table 91: evSpex - Product Status

Table 92: evSpex - Product Description

Table 93: Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview

Table 94: Drug-Eluting Contact Lenses - Product Status

Table 95: Drug-Eluting Contact Lenses - Product Description

Table 96: Eyenovations Pipeline Products & Ongoing Clinical Trials Overview

Table 97: Drug Dispensing Contact Lens - Product Status

Table 98: Drug Dispensing Contact Lens - Product Description

Table 99: EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview

Table 100: DSPEK - Product Status

Table 101: DSPEK - Product Description

Table 102: iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 103: iBIONICS Diamond Eye - Product Status

Table 104: iBIONICS Diamond Eye - Product Description

Table 105: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

Table 106: Contact Lens - Product Status

Table 107: Contact Lens - Product Description

Table 108: iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview

Table 109: STARvue - Product Status

Table 110: STARvue - Product Description

Table 111: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Table 112: Intra-corneal Implant - Product Status

Table 113: Intra-corneal Implant - Product Description

Table 114: Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 115: 1-DAY ACUVUE Multifocal Contact Lens - Product Status

Table 116: 1-DAY ACUVUE Multifocal Contact Lens - Product Description

Table 117: Anti-allergic Contact Lens - Product Status

Table 118: Anti-allergic Contact Lens - Product Description

Table 119: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

Table 120: Therapeutic Contact Lens - Product Status

Table 121: Therapeutic Contact Lens - Product Description

Table 122: McGill University Pipeline Products & Ongoing Clinical Trials Overview

Table 123: Portable System - Amblyopia - Product Status

Table 124: Portable System - Amblyopia - Product Description

Table 125: Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview

Table 126: First Aid Lens - Product Status

Table 127: First Aid Lens - Product Description

Table 128: Healing Lens - Product Status

Table 129: Healing Lens - Product Description

Table 130: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 131: Artificial Cornea - Product Status

Table 132: Artificial Cornea - Product Description

Table 133: Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 134: MicroBioSensor-Contact Lens - Product Status

Table 135: MicroBioSensor-Contact Lens - Product Description

Table 136: Monash University Pipeline Products & Ongoing Clinical Trials Overview

Table 137: Monash Vision - Product Status

Table 138: Monash Vision - Product Description

Table 139: Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 140: NR600 Implant - Product Status

Table 141: NR600 Implant - Product Description

Table 142: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview

Table 143: CLM041 - Product Status

Table 144: CLM041 - Product Description

Table 145: Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 146: Contact Lens - Dry Eye Disease - Product Status

Table 147: Contact Lens - Dry Eye Disease - Product Description

Table 148: Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 149: Third PEG Hydrogel Contact Lens - Product Status

Table 150: Third PEG Hydrogel Contact Lens - Product Description

Table 151: PixelOptics Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 152: Behold - Product Status

Table 153: Behold - Product Description

Table 154: Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview

Table 155: IRIS II Bionic Vision System - Product Status

Table 156: IRIS II Bionic Vision System - Product Description

Table 157: PRIMA - Product Status

Table 158: PRIMA - Product Description

Table 159: Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview

Table 160: Presbia Flexivue Microlens - Product Status

Table 161: Presbia Flexivue Microlens - Product Description

Table 162: Presbia Plc - Ongoing Clinical Trials Overview

Table 163: Presbia Flexivue Microlens - A Phase II trial of Presbia Flexivue Microlens for The Treatment of Presbyopia

Table 164: Presbia Flexivue Microlens - Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens for the Improvement of Near Vision in Emmetropic Presbyopes

Table 165: Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview

Table 166: Ophthalmic Lenses - Product Status

Table 167: Ophthalmic Lenses - Product Description

Table 168: Refocus Group Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 169: VisAbility Implant System - Product Status

Table 170: VisAbility Implant System - Product Description

Table 171: Refocus Group Inc - Ongoing Clinical Trials Overview

Table 172: VisAbility Implant System - A Prospective, Multicenter Clinical Trial of the VisAbility Implant System for Improvement of Near Visual Acuity in Presbyopic Patients

Table 173: RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 174: CLEAr Lens - Product Status

Table 175: CLEAr Lens - Product Description

Table 176: ReVision Optics Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 177: Raindrop Near Vision Inlay - Product Status

Table 178: Raindrop Near Vision Inlay - Product Description

Table 179: ReVision Optics Inc - Ongoing Clinical Trials Overview

Table 180: Raindrop Near Vision Inlay - A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., Raindrop Near Vision Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects

Table 181: Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview

Table 182: OcularColl - Product Status

Table 183: OcularColl - Product Description

Table 184: Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Table 185: Biological Neural Network Based Retinal Prosthesis - Product Status

Table 186: Biological Neural Network Based Retinal Prosthesis - Product Description

Table 187: Polymer Network Hydrogel Contact Lens - Product Status

Table 188: Polymer Network Hydrogel Contact Lens - Product Description

Table 189: Studio Oculistico Gualdi Pipeline Products & Ongoing Clinical Trials Overview

Table 190: PEARL Inlay - Product Status

Table 191: PEARL Inlay - Product Description

Table 192: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

Table 193: Bionic Eye - Product Status

Table 194: Bionic Eye - Product Description

Table 195: The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview

Table 196: Resonance Circuit Sensor Contact Lens - Product Status

Table 197: Resonance Circuit Sensor Contact Lens - Product Description

Table 198: The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview

Table 199: Stem Cell Contact Lens - Product Status

Table 200: Stem Cell Contact Lens - Product Description

Table 201: UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview

Table 202: Contact Lenses - Product Status

Table 203: Contact Lenses - Product Description

Table 204: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview

Table 205: Vision Screening System - Product Status

Table 206: Vision Screening System - Product Description

Table 207: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Table 208: Aerated Contact Lens - Product Status

Table 209: Aerated Contact Lens - Product Description

Table 210: Telescopic Contact Lens - Product Status

Table 211: Telescopic Contact Lens - Product Description

Table 212: University of Florida Pipeline Products & Ongoing Clinical Trials Overview

Table 213: Vitamin E - Packed Lenses - Product Status

Table 214: Vitamin E - Packed Lenses - Product Description

Table 215: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

Table 216: Keratoprosthesis - Product Status

Table 217: Keratoprosthesis - Product Description

Table 218: Transcorneal Telescope - Product Status

Table 219: Transcorneal Telescope - Product Description
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Medical Optics Inc
- Adoptics AG
- AkkoLens International BV
- Alcon, Inc.
- Anew Optics, Inc.
- Bausch & Lomb Inc
- Calhoun Vision, Inc.
- Clarvista Medical, Inc.
- Elenza,
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll